Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Safety & Quality
July 02, 2012 01:00 AM

GlaxoSmithKline agrees to pay $3 billion in largest U.S. healthcare fraud settlement

Joe Carlson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    (Story updated at 3:45 p.m. ET.)

    In the largest fraud settlement in U.S. history, GlaxoSmithKline has agreed to pay $3 billion in settlements and to plead guilty to criminal charges related to its branding, safety disclosures and price reporting of several drugs.

    The Justice Department on Monday announced a “global settlement” with the U.K.-based company that resolves three investigations related to the pharmaceutical giant and imposes an unusual corporate integrity agreement on Glaxo's worldwide operations.

    The company will pay $1.8 billion to resolve criminal and civil liabilities for off-label marketing, including $757 million in criminal fines for misbranding antidepressants Paxil and Wellbutrin, and more than $1 billion for alleged False Claims Act violations related to payments of kickbacks for those and other drugs.

    The company also agreed to pay a $243 million criminal fine for failing to report safety data to the Food and Drug Administration regarding its diabetes drug Avandia. The company will pay $657 million to resolve allegations about statements it made regarding Avandia's safety and efficacy.

    The corporation will plead guilty to two criminal charges of introducing misbranded drugs into commerce, related to Paxil and Wellbutrin, and one count of failing to report safety information for Avandia. In the cases of Paxil and Avandia, the company was forced to add prominent “black box” safety warnings to drug packaging after its conduct became known to authorities.

    Finally, the company will pay $300 million for allegedly failing to report its best prices for certain drugs to Medicaid, according to written comments from Stuart Delery, acting assistant attorney general for the Justice Department's Civil Division.

    The settlements still require approval from a U.S. District Court judge before becoming final. The civil settlements would resolve four whistle-blower lawsuits pending in U.S. District Court in Massachusetts, the Justice Department said.

    Glaxo is not admitting liability in the government's civil allegations, except to the extent that it agrees to the facts to which the corporation is pleading guilty in the three criminal charges filed against it.

    In a written statement, the company said the settlements will be paid with existing cash reserves, now that negotiations with various government agencies had concluded. The company will enter a corporate integrity agreement.

    “Today brings to resolution difficult, long-standing matters for GSK,” CEO Sir Andrew Witty said in a written statement. “On behalf of GSK, I want to express our regret and reiterate that we have learnt from the mistakes that were made.”

    As part of the global settlement the company will enter a novel corporate integrity agreement (PDF) effective until Dec. 31, 2017.

    The agreement forces Glaxo to change how it compensates sales staff, removing pay based on territorial sales goals, which was “one of the driving forces behind the conduct at issue in this matter,” the Justice Department wrote. The agreement also allows the company to recoup executive bonuses and incentive pay if they or their subordinates engage in misconduct.

    GSK stock rose after news of the settlement, climbing 1.6% to a share price of $46.30 in late afternoon trading on the New York Stock Exchange.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    coronavirus_covid-19_AP_edit_i.jpg
    Dominant coronavirus mutant contains ghost of pandemic past
    Pandemic-weary Americans plan for summer despite COVID surge
    Pandemic-weary Americans plan for summer despite COVID surge
    Sponsored Content
    COVID-19 Coverage Newsletter: Sign up today to receive a comprehensive daily newsletter designed for healthcare leaders looking for the most accurate and comprehensive resources related to coronavirus.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing